Statins, a popular class of cholesterol drugs, reverse the learning deficits caused by a mutation linked to a common genetic cause of learning disabilities, according to a paper in Nature Neuroscience using mice genetically engineered to develop the disease, called Noonan syndrome.
The disorder can disrupt a child's development in many ways, often causing unusual facial features, short stature, heart defects and developmental delays. No treatment is currently available.